Back to Journals » Chronic Wound Care Management and Research » Volume 4

Maggot debridement therapy: the current perspectives

Authors Naik G, Harding KG

Received 1 May 2017

Accepted for publication 4 September 2017

Published 3 October 2017 Volume 2017:4 Pages 121—128

DOI https://doi.org/10.2147/CWCMR.S117271

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Professor Marco Romanelli

Gurudutt Naik, Keith G Harding

Welsh Wound Innovation Centre, Cardiff University, Cardiff, UK

Abstract: Chronic wounds remain a challenge to most healthcare systems worldwide despite the technological advances we have seen to date. Many chronic non-healing wounds require alternative approaches, in addition to standard conventional therapies. Maggot debridement therapy (MDT) or the use of maggots to treat wounds is one such therapy that has been in use for centuries. We conducted a review of articles published in PubMed, NICE evidence documents, and linked literature with the aim of providing a brief perspective on the evolution of MDT, and the context in which maggot therapy is currently used along with evidence behind such methods.

Keywords: wound healing, maggot debridement therapy, debridement, Lucilia sericata, chronic disease, larva

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]